BGI provides a range of genomic solutions for newborn genetic screening including newborn genetic screening and newborn metabolic disease screening. More
BGI’s latest CE certified 3-in-1 test for SARS-CoV-2, Influenza A and Influenza B provides reliable single-panel-test diagnosis. More
BGI provides a wide range of clinical and research solutions for oncology including hereditary cancer screening and cancer precision medicine. More
BGI has provided over 10 million NIFTY® test to date for the patients worldwide, including NIFTY® test and NIFTY® Pro test. More
BGI's VISTA™ reproductive health solutions include carrier screening, preimplantation genetic screening, and chromosome sequencing. More
BGI provides high quality and cost efficient clinical exome sequencing solutions including clinical whole exome sequencing and exome sequencing for monogenic disease. More
BGI provides advanced screening test for colorectal cancer via high sensitivity - 96.08% for the patients worldwide.. More
BGI Human Whole Genome Sequencing services are executed with the DNBSEQ™ NGS technology platform with the benefit of lower cost and turn-around-times. More
BGI Transcriptome Sequencing services are executed with BGI’s unique DNBSEQ™ Technology Platform for great sequencing data at the lowest cost in the industry. More
BGI’s Single Cell Sequencing service is typically executed with DNBSEQ™ NGS technology platform for great sequencing data at the lowest cost in the industry. More
Note: Do not open in Word if you intend to import into a clinical software
Note: Do not open in Word if you intend to import into a clinical software
For Sending the Request Forms
Our Medical Objects Routing ID is HB40060009B
Or
Our HealthLink Routing ID is bgihthau.
Copyright © 2024 BGI Australia - All Rights Reserved
By continuing to use our site you agree to our use of cookies to deliver a better site experience.